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corroborate the beneﬁts of PFN.
0667: HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY: AN AID TO
DIAGNOSIS
S.J. Khan*, B.D. Sarmah. Heart of England NHS foundation Trust, UK
Aim: The aim of this study was to evaluate if Hexaminolevulinate (Hexvix)
ﬂuorescence cystoscopy improved bladder tumour identiﬁcation and man-
agement andwhether repeated episodes ofHexvix incurred further beneﬁts.
Methods: All patients undergoing Hexvix cystoscopy at a District General
Hospital between October 2008 and October 2014 were incorporated. Data
collected and analysed included reason for Hexvix, repeats of Hexvix,
ﬁndings at white-light and Hexvix cystoscopies, complications, histology
and outcomes.
Results: Sixty cases of Hexvix cystoscopies were performed on forty-nine
patients. Nine had repeats and two had a further third episode. No
complications were reported. Reasons for Hexvix included thirty-eight
(63%) for surveillance/abnormal ﬂexible cystoscopy, ten (16.7%) post-BCG
treatment and ten (16.7%) persistently abnormal urine cytology. Twenty-
two (36.7%) conﬁrmed bladder carcinoma. Twenty-two cases docu-
mented white-light and Hexvix ﬁndings. Twelve described no abnor-
malities with white-light which ﬂuoresced using Hexvix. Of these, ﬁve
conﬁrmed malignancy. Three of nine patients conﬁrmed bladder malig-
nancies after the initial Hexvix. Subsequent repeats detected no
abnormalities.
Conclusion: Hexvix improved the detection of bladder tumours, particu-
larly in CIS/pT1G3 tumours. It highlighted areas of malignancies not
visualised by white-light cystoscopy. No additional beneﬁts were seen
from repeating Hexvix cystoscopies.
0680: META-ANALYSIS OF HOLMIUM LASER ENUCLEATION VERSUS
TRANSURETHRAL RESECTION OF PROSTATE FOR PATIENTS WITH
BENIGN PROSTATIC OBSTRUCTION
O. Naser 1,*, A. Negida 2, E. Kasem 2, A. Mokhtar 3, A. Menshawy 4, T.
Badawy 5, A.S. Turky 3, A. Tammam6, A. El-Sawaf 3, B. Gana 1. 1West
Wales General Hospital, UK; 2 Zagazig University, Egypt; 3Menouﬁa
University, Egypt; 4Azhar University, Egypt; 5Alexandria University, Egypt;
6Cairo University, Egypt
Aim: This meta-analysis aims at comparing Holmium laser enucleation
(HoLEP) versus transurethral resection of prostate (TURP) for patients with
benign prostatic obstruction.
Methods: PubMed was searched for RCTs comparing HoLEP versus TURP
using relevant search terms. Data were extracted from eligible studies
and were analyzed using RevMan 5.3 for windows. In case of multiple
reports for the same patients, we analyzed data from the most recent
dataset.
Results: Nine RCTs (871 patients) were included in the ﬁnal analysis.
Follow up ranged from 6 to 92 months. For perioperative outcomes, he-
moglobin loss (SMD¼-0.41, 95% CI¼[-0.60, -0.22]) and blood transfusion
(RR¼0.17, 95% CI¼[0.05, 0.65]) were less in HoLEP than TURP. For post-
operative outcomes, maximum ﬂow rate (SMD¼0.15, 95% CI¼[0.00, 0.29])
and post-void residual volume (SMD¼-0.27, 95% CI¼[-0.46, -0.08]) were
better in HoLEP than TURP. There was no difference in terms of IPSS
(SMD¼-0.01, 95% CI¼[-0.20, 0.19]), AUA symptom score (SMD¼-0.16, 95%
CI¼[-0.35, 0.02]) or QoL (SMD¼0.14, 95% CI¼[-0.06, 0.33]). The overall
relative risk of urethral strictures, incontinence and recatheterization did
not favor either of the two modalities.
Conclusion: HoLEP achieved better changes in Qmax and PVR than TURP.
Hemoglobin loss and perioperative blood transfusion were less in HoLEP
than TURP.
0757: A SERVICE IMPROVEMENT PROJECT FOR EMERGENCY
UROLOGICAL ADMISSIONS
T. Tharakan*, C. Wou, A. Phaily, W. Dunsmuir. Ashford and St Peter's
Hospital NHS Foundation Trust, UKAim: IncreasingA&Eattendances have resulted inmore emergency urology
referrals and subsequent admissions. At our Trust, the surgical senior house
ofﬁcer (SHO) is the gatekeeper for patients with possible urological prob-
lems. Our Trust has moved to a consultant-led service with loss of registrar
cover out-of-hours. A previous Trust audit concluded 29% of all emergency
urological admissions were inappropriate. The registrar timetable was
therefore reconﬁgured to extend their hours from 8pm to 10pm to support
the SHO. This re-audit reviewed admissions after these changes.
Methods: We retrospectively reviewed the notes of 77 patients who were
admitted under the urology team during one month and compared results
to the previous audit.
Results: Total preventable admissions dropped by 11%. Half of these ad-
missions could be managed at home. 72% of inappropriate admission were
admitted out-of-hours. Collectively, these patients stayed in hospital for a
total of 46 days. The total cost for these days is estimated to be over £15,000.
Conclusion: Improvements in registrar timetabling resulted in a 11%
decrease in inappropriate urological admissions, highlighting the impor-
tance of senior support and potential ﬁnancial savings. Further investiga-
tion into the causes of inappropriate admissions is required e.g. depth of
urological knowledge of admitting SHOs.0758: TIMING OF SECOND RESECTION IN HIGH-GRADE NON-MUSCLE-
INVASIVE BLADDER CANCER: DOES DELAY ADVERSELY AFFECT
OUTCOME?
J. Fitzpatrick, D.R. Biju*, T. Amer, R. Hutton, B. Nair. University Hospital Ayr,
UK
Aim: In non-muscle-invasive bladder cancer (NMIBC), there is a risk that
residual tumour may be present after initial resection and that the tumour
is under-staged. There is still debate regarding the optimum timing of
second resection although current guidelines advocate 2-6 weeks. The aim
was to determine whether delay to second resection adversely affects
disease outcomes in NMIBC.
Methods: This was a retrospective analysis of 56 patients with high-grade
(G3) NMIBC from 2005-2010 who underwent repeat resection following
initial TURBT. Data was collected from online databases.
Results: The majority of patients (61%; 34/56) had T1 disease. Out of 56
patients, 50% (28/56) had evidence of residual tumour on repeat resection;
14% (8/56) had been under-staged and 50% (4/8) of these had muscle-
invasive disease which altered treatment. During follow-up, 61% (34/56)
developed recurrence and 25% (14/56) disease progression. Time to second
resectionwas <6 weeks in 30% (17/56) and >6 weeks in 70% (39/56). There
was no signiﬁcant difference in recurrence (76%:54%, p¼0.11) or progres-
sion (35%:21%, p¼0.24) between these two groups.
Conclusion: We ﬁnd no signiﬁcant difference on adverse outcomes when
repeat resection is delayed beyond 6 weeks. Further research is required to
determine the optimum timing for repeat resection.0783: ASSESSMENT OF CLINICAL OUTCOMES OF ORTHOTOPIC NEO-
BLADDER RECONSTRUCTION AFTER RADICAL CYSTECTOMY
A. Anwar*, G.M. Nandwani, R. Singh, R. Chahal, S. Addla. Bradford Royal
Inﬁrmary, UK
Aim: In reconstructive urology orthotopic neobladder is the diversion of
choice. It does not compromise oncological outcome, yields excellent
functional results and cost effective compare to incontinent diversions.
Methods: 128 patients underwent radical cystectomy April 2009 till
October 2014. 109 ileal conduit and 19 had orthotopic neobladder recon-
struction(ONB). Data collected from hospital notes, electronic records.
Patients evaluation on functional outcomes (incontinence, infection, uri-
nary retention, self catheterisation, oncological outcomes (cancer free
survival(CSS), overall survival(OSS), cancer recurrence, pathological stag-
ing) and surgical complications (Clavien-Dindo).
Results: Total n¼19 ONB reconstruction (male¼16, female¼3), age 67 ± 21
years, 67%(n¼12) ASA-1, 37%(n¼7), duration of surgery 370 ± 110 minutes,
blood loss 700 ± 500 mls, Mortality(n¼1) secondary to chest infection. CSS
100%(n¼18) and OSS 94.7% at a median follow-up of 36 ± 14 months. Local
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upstaged, 61% down-staged and 22% unchanged. Day time urinary in-
continence 0%, Nocturnal incontinence 27.7%, continent 72.3%, failure to
void and Intermittent self catheterisation 27.7%. Average neo-bladder ca-
pacity 700-1400mls.
Conclusion: Downward trend noted in ONB reconstruction. Postop blood
transfusion none ;hospital stay 10 days. Higher self-catheterisation (CISC)
rate in male patients, urinary continence and complications rate are
equally comparable to other published series.
0795: TRIAL WITHOUT CATHETER; ARE WE FAILING OUR PATIENTS?
A. Anwar*, J. Makanjuola, M. Ahmed. Princess Royal University Hospital, UK
Aim: Acute urinary retention (AUR) is the most common urological
emergency with an incidence of approximately 3/1,000 men per annum in
England. Long waiting time for appointment to trial without catheter
(TWOC) clinics causing wide range of complications affecting patient’s
quality of life and burdened the NHS. This study was conducted to evaluate
TWOC clinic services across the UK.
Methods: Data collected through validated questionnaire uploaded to
senior urology registrar group(SURG) website, via controlled access to a
national list of www.nhs.net e-mail addresses of health professionals,
telephonic feedback and direct contact in urology meetings.
Results: TWOC available in 100% district hospitals. Urology nurse practi-
tioners(89.4%) doctors(5.3%) and healthcare assistants(5.3%) conducts the
clinics. 47% clinics scheduled twice per week. Average appointment time is
7-14days(55%). Prior to TWOC selective alpha-blocker prescribed in 92%.
Appointments booked through Urologist are 42%,(GP)10% and (A&E)40%.
71% patients spent 2-4 hrs and 13% spent>4hrs in TWOC clinics. 55.5%
clinics record ﬂow rate and residual urine. Only 26% departments do
regularaudits. 76% responders are satisﬁed from TWOC services others not
because of long waiting time.
Conclusion: The results high-lightened the risk associated aspects of the
care provision. It also raises the concerns about the quality of service and
areas of potential improvement.0802: ROLE OF IMAGING IN FOLLOW-UP AFTER RADICAL CYSTECTOMY
M. Chakravorty 1,*, M.S. Khan 2. 1University of Shefﬁeld, UK; 2Guys' and St
Thomas' NHS Foundation Trust, UK
Aim: We aim to devise an evidence-based up-to-date schedule for follow-
up imaging post-cystectomy for muscle-invasive bladder cancer: stratiﬁed
according to risk factors, recurrence timings, and relative survival beneﬁts
of early asymptomatic detection.
Methods: Medline and relevant EAU and AUA guidelines reference lists
were searched to identify appropriate papers for inclusion.
Results: CT and chest X-ray are best for detecting local and distant me-
tastases; MRI is a sensitive, non-ionising alternative. Trans-rectal ultraso-
nography may be effective in local recurrence detection.
80-90% of recurrences occur within three years: high stage and grade of
the primary tumour, and positive invasion status at cystectomy increase
risk. Local (pelvic) and distant (bone, liver and lung) metastases are more
likely to recur within the ﬁrst year, especially in high-risk groups. Early
detection is associated with longer survival times. After three years, uro-
thelial tumours are more likely to recur; however, there are no signiﬁcant
survival beneﬁts to routine imaging.
Conclusion: We propose three strata of patients: high risk (high grade/
stage), intermediate, or low. In the ﬁrst three years: high-risk patients
should be imaged 6-monthly; low-risk, annually; and patients with in-
termediate-risk, 6-monthly in the ﬁrst year, then annually. After three
years, imaging should be guided based on symptoms.
0804: ARE WE REQUESTING BONE SCANS APPROPRIATELY?
M. Pereira*, I. Ward, M.I. Johnson. Freeman Hospital, UK
Aim: To correlate the results of prostate cancer patient’s bone scans (BS)
with their PSA and pathology ﬁndings.Methods: A retrospective study of all BS performed between April and June
atourhospital, inpatients known tohave prostate cancer. The following data
was collected: age, BS reports, latest PSA, Gleason score and further imaging.
Results: During this period, 247 BS were performed. From these 167 BS
were performed for patients with prostate cancer. There were 141 patients
that were not known to have bone metastasis. In this group 19% had PSA
<10, and 26% had PSA 10-20. 19% of these BS were equivocal and required
further imaging, but after additional imaging were negative.
Overall no patient with PSA <20 had bone metastasis conﬁrmed, and also
25% of BS were positive e all of which had PSA >20. The likelihood for the
patient to have metastatic bone disease with PSA <20 is very low. The
ﬁnding of equivocal scans requires further imaging, which adds cost for the
NHS and stress for the patient.
Conclusion: The PSAvalue is a valuable tool for prediction of positive bone
scan, and it can be used to rationalise requesting bone scan and avoid
patient distress.
0838: ROLE OF PATHOLOGICAL EXAMINATION OF VAS DEFERENS IN
VASECTOMY
P. Cleaveland*, A. Doyle, M. Badat, B. Zelhof. Lancashire Teaching Hospitals
Trust, UK
Aim: Vasectomy is the most reliable form of male contraception. Current
practice at Royal Preston Hospital is to send the vas for pathological ex-
amination to conﬁrm its excision. The European Association of Urology and
Royal College of Reproductive Medicine Guidelines state that there is no
need for routine pathologic examination of the vas. Success of the proce-
dure is conﬁrmed by semen analysis at 12 weeks.
Methods: All males who underwent vasectomy in the trust from January
to December 2013 were included in the audit. Case notes and electronic
records were reviewed. Parameters including demographics, surgical
technique, histology, semen analysis and complications were recorded.
Results: 61 vasectomies were performed. Mean age was 39.5. 70.5% were
done under local anaesthetic. Vas histology was performed in 85.2% with
only 3.3% showing incomplete excision. 2 patients underwent re-do va-
sectomy due to positive semen analysis. One of these had normal vas
histology and the other the vas wasn’t found.
Conclusion: Pathological examinationof thevasdeferensdoesnotcontribute
to determining whether a vasectomy has been successful. Semen analysis is
the optimal test. We recommend that pathological examination of the vas is
no longer performed in our trust which will save costs and resources.
0895: OUTCOMES OF AUGMENTATION CYSTOPLASTY
S. Husain*, J. Bechar, M. Belal. University Hospitals Birmingham NHS
Foundation Trust, UK
Aim: To review postoperative complications for Augmentation Cystoplasty
procedures carried out in the Trust and to evaluate the quality of life (QoL)
of these patients post procedure.
Methods: A retrospective case note review for procedures in the last 3
years (August 2011 to 2014). Data on basic patient demographics, indica-
tion for surgery, procedure performed and post-operative complications
evaluated against Clavien-Dindo Classiﬁcation and documented. QoL
assessed using validated measures: EQ-5D-5L Health questionnaire and
ICIQ-UI Incontinence questionnaire.
Results: In total, 15 patients were identiﬁed in the last 3 years. Indi-
cation for surgery: 7 congenital and 8 acquired causes. 8 cases had
additional Mitrofanoff procedure. Overall, 8 cases had Clavien 1 com-
plications, 5 cases had Clavien 2 complications and 2 cases had Clavien
3b complications. EQ-5D-5L Health questionnaire conducted found an
average Mobility score 2.625, Self-care score 1.875, Usual activity score
1.875, Pain/discomfort score 1.875 (Score Min 1, Max 5). Average
Global Health percentage 66.25%. Average ICIQ score ¼ 3.375 (Min 0,
Max 21).
Conclusion: Overall, complications following Augmentation Cystoplasty
were in keeping with other centres, based on current literature. Patients
largely expressed a good QoL, with minimal post-procedure incontinence
reported.
